This makes BUB1B one of the most frequently mutated genes described in our HPC patients, accounting for 1.9% of the early-onset/familial PrCa patients and 2.5% of the patients with early-onset disease (diagnosis < 56 years). This evidence concerns the gene BUB1B and pure red-cell aplasia.